TNPSC Thervupettagam

Aktocyte tablets for cancer

December 18 , 2023 342 days 537 0
  • Department of Atomic Energy (DAE) and Bengaluru-based IDRS Labs have joined hands to develop Aktocyte tablets for treating pelvic cancer.
  • The Aktocyte tablets have shown remarkable results, particularly in pelvic cancer patients suffering from radiotherapy-induced Cystitis (blood in urine).
  • It will be eliminating the need for surgical removal of the urinary bladder.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories